PHIO

Phio Pharmaceuticals Corp.

Price

$1.03

return (12m)

-50.24%

p/e

-0.95

p/bv

0.97

DIVIDEND YIELD

0.00%

PHIO price

Phio Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PHIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.21%

3 months

-1.90%

1 year

-50.24%

2 years

-70.74%

5 years

-99.56%

10 years

-100.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PHIO

Valuation

P/E

-0.95

Sector -3.50

Industry -3.50

P/BV

0.97

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

0.19

Sector -214.99

Industry -214.99

EV/EBIT

0.19

Sector -47.59

Industry -47.59

P/EBITDA

-0.91

Sector -21.41

Industry -21.41

P/EBIT

-0.91

Sector -28.65

Industry -28.65

P/Total Assets

0.85

Sector 1.19

Industry 1.19

P/Net Current Assets

0.97

Sector -11.97

Industry -11.97

P/Working Capital

0.85

Sector -167.95

Industry -167.95

EPS

-1.11

Sector -1.81

Industry -1.81

BVPS

1.08

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-102.40%

Sector -56.04%

Industry -56.04%

ROA

-90.19%

Sector -60.31%

Industry -60.31%

ROIC

-179,705.26%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

3.05

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

3.04

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.03

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.88

Sector 0.46

Industry 0.46

Liabilities/Assets

0.12

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-0.58%

Sector -

Industry -

Fundamentals PHIO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PHIO Phio Pharmaceuticals Corp.	$1.03	-50.24%	0.00%	-0.95	0.97	-102.40%	0.00%
JNJ Johnson & Johnson	$269.99	56.71%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.66	23.21%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.96	22.44%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.24	-26.07%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.87	87.26%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.08	10.74%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.06	48.20%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.40	-50.11%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$385.65	38.85%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.85	33.10%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.45	44.52%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.65	25.89%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$508.34	32.68%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.38	52.58%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$990.32	34.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.02	29.13%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PHIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Phio Pharmaceuticals

Phio Pharmaceuticals Corp.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2012

Time since IPO - 14 years

11

Employees

Phio Pharmaceuticals Corp. (United States) is listed on the Nasdaq and has a market capitalization of $12.20 million, with shareholders equity totaling $12.60 million.

The company employs approximately 11 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Phio Pharmaceuticals Corp. reported $- in revenue, generating net income of $-12.90 million.

Key financial metrics include a P/E ratio of -0.95, a price-to-book (P/B) ratio of 0.97, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PHIO.

Market cap

$12.20 million

Net worth

$12.60 million

$12,602,000.00

Assets

$14.31 million

$14,307,000.00

Total Shares Outstanding

11.62 million

11,617,000

Average Daily Trading Volume

$714.37 Thousand

$714,367.96

Sector

Health Care

Industry

Biotechnology

PHIO

PHIO revenue and profits

Financial Results PHIO

DRAG THE FRAME TO SEE MORE DATA

PHIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.65 25,89% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.38 52,58% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.96 22,44% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.87 87,26% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.08 9,00% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.66 23,21% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.65 25,89% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.38 52,58% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.96 22,44% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.87 87,26% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.08 9,00% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.66 23,21% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Phio Pharmaceuticals (PHIO) today?

A cotação de Phio Pharmaceuticals (PHIO) hoje está em US$ 1.03, com uma variação de -50.24% em relação ao último ano. A cotação de Phio Pharmaceuticals (PHIO) iniciou o ano negociando na casa dos US$ 1.05 e hoje está em US$ 1.03. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Phio Pharmaceuticals (PHIO) e dados de ações do Ibovespa e mercados internacionais.

Quando Phio Pharmaceuticals (PHIO) paga dividendos?

Phio Pharmaceuticals (PHIO) não distribuiu dividendos no último ano.

Is Phio Pharmaceuticals (PHIO) a good investment?

Atualmente, Phio Pharmaceuticals (PHIO) está cotada a US$ 1.03, com um P/L de -0.95, representando um desvio de -58% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -50.24 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -50.24%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Phio Pharmaceuticals (PHIO) stock?

Investir em ações de Phio Pharmaceuticals (PHIO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Phio Pharmaceuticals (PHIO) yield today?

A rentabilidade de Phio Pharmaceuticals (PHIO) foi de -11.21% no último mês, -50.24% no último ano e -99.56% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Phio Pharmaceuticals (PHIO) hoje, o investimento total seria de US$ 103.00, com base na cotação atual de US$ 1.03.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 51.25
Em 5 anos: US$ 0.45
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PHIO

Phio Pharmaceuticals Corp.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PHIO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PHIO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Phio Pharmaceuticals

Phio Pharmaceuticals Corp.

United States

15 years

2012

11

PROFIT X PRICE PHIO

Financial Results PHIO

PHIO cash flow

Asset, Revenue and Profit Growth - PHIO

PHIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions